Mavodelpar sodium
| CAS No. | 1604815-32-8 | Cat. No. | BCP49236 |
| Name | Mavodelpar sodium | ||
| Synonyms | Mavodelpar;HPP-593; HPP593; HPP 593; REN-001; REN 001; REN001; | ||
| Formula | C31H29FNNaO5 | M. Wt | 537.55 |
| Description | Mavodelpar is a selective PPARδ agonist. Mavodelpar suppresses glomerular injury and renal fibrosis. Mavodelpar can be used for the research of primary mitochondrial myopathies (PMM) and long-chain fatty acid oxidation disorders (LC-FAOD). | ||
| Pathways | Cell Cycle/DNA Damage | ||
| Targets | PPAR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.